Solid Biosciences (SLDB) Retained Earnings (2017 - 2026)

Solid Biosciences has reported Retained Earnings for 10 years, with the latest figure at -$1.0 billion in Q1 2026.

• Quarterly Retained Earnings fell 50725700.0% year-over-year to -$1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 50725700.0% YoY) and the FY2025 annual result came in at $52000.0, up 100.01% from the prior year.
• Retained Earnings eased to -$1.0 billion in Q1 2026 per SLDB's latest filing, from $52000.0 in the prior quarter.
• Over five years, Retained Earnings peaked at $52000.0 in Q4 2025 and troughed at -$1.0 billion in Q1 2026.
• A 5-year average of -$342.5 million and a median of -$68000.0 in 2022 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2025 and 2026: Retained Earnings surged 150.0% in 2025, then slumped 50725700.0% in 2026.
• Over 5 years, Retained Earnings stood at -$68000.0 in 2022, then soared by 122.06% to $15000.0 in 2023, then slumped by 5223100.0% to -$783.4 million in 2024, then surged by 100.01% to $52000.0 in 2025, then sank by 1951084.62% to -$1.0 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$1.0 billion, $52000.0, and -$908.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.